Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity ; volume:14 ; number:1 ; day:2 ; month:11 ; year:2022 ; pages:1-12 ; date:12.2022
Alzheimer's research & therapy ; 14, Heft 1 (2.11.2022), 1-12, 12.2022
- Urheber
-
Tsiknia, Amaryllis A.
Sundermann, Erin E.
Reas, Emilie T.
Edland, Steven D.
Brewer, James B.
Galasko, Douglas
Banks, Sarah J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-022-01106-4
- URN
-
urn:nbn:de:101:1-2023011721000933675626
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tsiknia, Amaryllis A.
- Sundermann, Erin E.
- Reas, Emilie T.
- Edland, Steven D.
- Brewer, James B.
- Galasko, Douglas
- Banks, Sarah J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biological markers of Alzheimer's disease
MT5-MMP, just a new APP processing proteinase in Alzheimer’s disease?
Alzheimer’s Disease
Clinical importance in Alzheimer’s disease: effects of anchor agreement and disease severity
Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity
Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach
Alzheimer's disease
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
Biological markers of Alzheimer's disease
MT5-MMP, just a new APP processing proteinase in Alzheimer’s disease?
Alzheimer’s Disease
Clinical importance in Alzheimer’s disease: effects of anchor agreement and disease severity
Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity
Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach
Alzheimer's disease
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
Biological markers of Alzheimer's disease
MT5-MMP, just a new APP processing proteinase in Alzheimer’s disease?
Alzheimer’s Disease
Clinical importance in Alzheimer’s disease: effects of anchor agreement and disease severity
Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity
Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach
Alzheimer's disease
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP